Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

Hong Kong Drug Licence FAQs

Search 500 Hong Kong drug licence FAQs on applications, personnel, premises, quality systems, ongoing regulation, renewals and acquisitions.

Information status: The original FAQ material dates from 2025 and is provided for topic-based reference; it does not represent an individual verification of all 500 FAQs against current rules. For application, fee, renewal, change, product or prescription requirements, please refer to the current official forms and guidance.

Official information from the Drug Office Official information from the Chinese Medicines Board

找到 100 条结果,第 5/5 页。每页显示 20 条;无需启用 JavaScript。

Thematic illustration for pharmaceutical licensing business queries and document organisation services
Discuss actual operating questions one-to-one to clarify the next decision.
Q316 · 如何制定和执行一份有效的仓库清洁与卫生(Cleaning and Sanitation)SOP?独立链接
Keeping the warehouse clean and hygienic is fundamental to preventing cross-contamination of medicines and ensuring appropriate storage conditions. An effective cleaning SOP should be highly practical. It should clearly specify: 1. The scope of cleaning: all areas, including floors, shelving, walls, ceilings and equipment surfaces; 2. Cleaning frequency: for example, floors daily and shelving weekly; 3. Cleaning tools and agents: specific types must be identified, and these materials must not contaminate medicines; 4. Detailed cleaning methods and steps: for example, working from top to bottom and from inside to outside; 5. Post-cleaning inspection criteria: achieving a “visibly clean” standard; 6. Cleaning records: a designated person should complete a cleaning log recording the date, time, person carrying out the cleaning and person inspecting it. There should also be a specific procedure for dealing with accidental spills, such as leakage from damaged medicines.

📘 Regulatory basis

The Good Distribution Practice (GDP) for Medicinal Products sets out clear requirements for cleaning storage areas, which must be kept clean and dry and maintained within acceptable temperature limits. Written cleaning procedures and records must be in place to demonstrate that cleaning has been carried out effectively.

📗 Drew Tang's recommendations

Assign cleaning responsibilities to specific personnel and train them on the relevant SOPs. Design cleaning logs to be clear and easy to complete. We recommend periodically validating cleaning effectiveness, for example by using ATP bioluminescence testing to quantify surface cleanliness, although this is not mandatory. Importantly, management should demonstrate its commitment to cleanliness and hygiene through inspections and foster a positive workplace culture.

📕 Risk notice

A dirty and untidy warehouse is the most obvious sign of GDP non-compliance. Dust, stains and accumulated rubbish can all become sources of microbial growth and cross-contamination. During a regulatory inspection, if cleaning logs are missing or clearly inconsistent with the actual conditions on site, inspectors may conclude that your SOPs and quality system exist only “on paper” and are not being implemented.

Q317 · 当客户退回药品时,我应该如何处理?退回的药品可以重新销售吗?独立链接
Returns are a high-risk area and must be governed by a strict SOP. First, all returned drugs must be identified immediately and quarantined in a dedicated, secure returns area to prevent them from inadvertently re-entering saleable stock. An authorised member of the quality department must then carefully assess the returned drugs to determine their final disposition. Only if very strict conditions are met may drugs be considered for return to saleable stock. These conditions include the drugs remaining in their original, unopened packaging; storage conditions having been maintained throughout (for example, with evidence that the cold chain was not interrupted); sufficient remaining shelf life; and inspection and approval by a qualified person. Any drugs that do not meet these conditions must be destroyed.

📘 Regulatory basis

Chapter 6, “Complaints, Returns, Suspected Falsified Medicinal Products and Medicinal Product Recalls”, of the Good Distribution Practice (GDP) for Medicinal Products sets out detailed requirements for handling returns. It expressly states that returned medicines must undergo a risk assessment before their disposition is decided, and that the conditions for returning them to stock for sale are very stringent.

📗 Drew Tang's recommendations

Our core recommendation is to take the most conservative approach to returns: “When in doubt, destroy.” Reselling returned medicines carries a very high risk, as it is difficult to be absolutely certain about the storage conditions they were kept in after leaving your warehouse. It is vital to keep clear records of the receipt, assessment and disposal of returns. Strictly reserve decisions on handling returns to the quality department, so that sales pressures do not affect quality judgements.

📕 Risk notice

Incorrectly returning non-conforming returned medicines to stock for sale poses an extremely serious quality and safety risk. If the medicines have deteriorated or have been stored improperly, they could harm patients. If discovered by regulators, this will be regarded as a serious GDP breach and may result in your licence being suspended or revoked immediately.

Q325 · 在GDP中,“验证”(Validation)和“确认”(Qualification)有何区别?哪些系统或设备需要做?独立链接
“Qualification” and “validation” both demonstrate that a system, equipment or process can consistently achieve its intended results, but they have different emphases. “Qualification” is usually applied to equipment, facilities and systems. It demonstrates that the “hardware” itself has been installed correctly, operates correctly and is suitable for its intended use. It usually comprises four stages: design qualification (DQ), installation qualification (IQ), operational qualification (OQ) and performance qualification (PQ). Qualification of a new refrigerator is one example. “Validation” focuses more on the “process”: it demonstrates that a complete process or method can consistently produce results that meet predetermined standards. Examples include transport validation of a cold-chain packaging solution and validation of a computerised system. In short, qualification is the foundation for validation: equipment is usually qualified first, followed by validation of the processes that use it.

📘 Regulatory basis

The Good Distribution Practice (GDP) for Medicinal Products requires critical equipment affecting the quality of medicines (such as cold rooms and refrigerators) and computerised systems to be qualified or validated before use, to demonstrate their suitability. Requalification or revalidation may be required after any significant change.

📗 Drew Tang's recommendations

We recommend that clients use a risk-based approach to determine the scope and depth of validation/qualification. Critical systems that directly affect product quality, such as temperature control systems and warehouse management systems (WMS), must undergo rigorous validation/qualification. All activities should be planned in advance in a protocol, followed by a report, with a complete documentary record. As this work requires specialist expertise, you may wish to engage a specialist third-party service provider to assist.

📕 Risk notice

Using critical equipment or systems that have not been qualified or validated is a serious GDP breach. For example, if you use an unqualified refrigerator to store vaccines, you will be unable to demonstrate to the regulator that their quality was maintained during storage. This may result in an entire batch being deemed non-conforming and put your licence at risk.

Q326 · 什么是“校准”(Calibration)?哪些仪器设备必须进行校准,频率如何?独立链接
Calibration is the process of comparing the reading of a measuring instrument, such as a thermometer, hygrometer or weighing scale, with a recognised, more accurate standard traceable to international or national standards, in order to determine and record its accuracy. If a deviation beyond the acceptable range is found, the instrument must be adjusted or replaced. In the wholesale of medicines, all instruments used to monitor and control critical parameters that affect medicine quality must be calibrated regularly. These include all probes used to monitor temperature and humidity in warehouses and refrigerators, temperature loggers used in cold-chain transport, and electronic scales used to weigh medicines. Calibration ensures that the data on which you rely to make quality decisions is accurate and reliable.

📘 Regulatory basis

The Good Distribution Practice (GDP) for Medicinal Products expressly requires all critical equipment used to monitor storage conditions to be calibrated in accordance with established procedures. Calibration activities must be recorded, and the calibration status must be clearly identifiable (for example, by means of a calibration label).

📗 Drew Tang's recommendations

We strongly recommend engaging a qualified third-party professional calibration organisation, such as one accredited under the Hong Kong Laboratory Accreditation Scheme (HOKLAS), to carry out calibration. It can provide traceable calibration certificates, which are the strongest evidence of compliance. The calibration frequency should be determined based on a risk assessment, the manufacturer's recommendations and the stability of the instrument, but temperature and humidity probes are usually calibrated at least once a year. Keep all calibration certificates and attach a label to each instrument showing the date of its next calibration.

📕 Risk notice

Data generated using instruments that have not been calibrated or are overdue for calibration is invalid. For example, if all temperature records in your warehouse come from an uncalibrated probe, none of your temperature control measures are supported by evidence. This is a basic but serious deficiency during a regulatory inspection, and inspectors will immediately question the authenticity of all related records.

Q330 · 我的QMS中是否需要包含业务连续性计划(BCP)或应急计划?独立链接
Yes, a mature QMS should include a Business Continuity Plan (BCP) to address unexpected events that may interrupt your critical operations. Such events may include natural disasters (such as a typhoon causing a power failure), fire, serious IT system failures, the collapse of a key supplier or the warehouse becoming unusable. The core purpose of a BCP is to identify these risks in advance and establish an action plan to ensure that critical products and services can continue to be provided at a predetermined, acceptable level during a crisis. This is particularly important for medicine wholesalers, as an interruption to medicine supply may directly affect patient treatment. The plan should include an emergency command structure, internal and external communication arrangements, data backup and recovery procedures, and arrangements for alternative facilities or suppliers.

📘 Regulatory basis

Although GDP does not expressly require a complete BCP in the same way as financial regulation, its principles underpin multiple requirements, such as backup power and alarm systems for cold rooms and reliable data backup procedures. These are all components of a BCP. A quality system that cannot respond to unexpected events is incomplete.

📗 Drew Tang's recommendations

Start by identifying the few key processes that matter most to your business, such as the storage and distribution of cold-chain medicines. Then consider the most likely disruption scenarios for those processes and establish simple, practical response steps. For example, enter into a framework agreement with a backup cold-chain transport company. Test your contingency plan regularly, such as checking that a backup generator starts or that data can be restored from a backup. Treat your BCP as an investment in your business resilience.

📕 Risk notice

In a crisis, a company without an emergency plan can fall into disarray and make poor decisions, potentially worsening the impact on medicine quality and supply. For example, following a prolonged power cut, the entire stock of cold-chain medicines in a warehouse could be lost if there is no backup power supply or emergency relocation plan. Showing the regulatory authorities that you are prepared for foreseeable emergencies will greatly increase their confidence in your management capabilities.

Q335 · GDP对员工的“个人卫生”(Personal Hygiene)有哪些具体要求?应如何体现在SOP中?独立链接
Although pharmaceutical wholesale does not have the extreme environmental requirements of sterile manufacturing, good personal hygiene remains a basic element in preventing medicine contamination. GDP requires companies to establish and implement relevant hygiene procedures. Your hygiene SOP should specify that: 1. All employees entering medicine storage and handling areas must wear clean work clothes; 2. Hands must be cleaned appropriately before handling medicines; 3. Employees who have an infectious disease that could contaminate medicines or open skin wounds must report it to a supervisor immediately and be temporarily removed from duties involving direct contact with medicines; 4. Eating, drinking, smoking or keeping personal food and belongings in medicine storage and handling areas is strictly prohibited; and 5. Personal clothing must be kept clean. These requirements are intended to minimise the risk of medicine contamination from human factors.

📘 Regulatory basis

Chapter 2, “Personnel”, of the Good Distribution Practice (GDP) for Medicinal Products requires appropriate hygiene procedures to be established. It also requires that anyone whose health condition could adversely affect product quality must not participate in the relevant activities.

📗 Drew Tang's recommendations

Make personal hygiene a compulsory part of new-employee induction training. Put reminder posters in prominent places, such as warehouse entrances, with messages such as “Clean your hands” and “No food or drink in work areas”. Provide staff with the necessary facilities, such as hand sanitiser, hand towels and suitable workwear. Management should lead by example in observing hygiene requirements and foster a culture that values cleanliness and professionalism.

📕 Risk notice

Although cases of medicine contamination directly caused by personal hygiene issues are uncommon in the wholesale sector, they reflect the company’s overall quality culture and management standards. If inspectors see staff in dirty clothes eating snacks in the warehouse, they may immediately have serious doubts about your company’s discipline and professionalism and may intensify their scrutiny of other areas as a result.

Q343 · 为确保库存准确和防止混淆,有哪些库存管理的最佳实践?独立链接
Accurate inventory management is the foundation of GDP, and is key to effective traceability and error prevention. Best practices include: 1. **Clear location management**: Assign a unique code to every shelf, level and location in the warehouse, and link product information to the location code in the system. 2. **Status segregation**: Strictly separate inventory with different statuses, both physically and in the system, such as “released goods”, “quarantined goods pending examination”, “returned goods” and “non-conforming goods / goods pending destruction”, and use clear signs to identify each area. 3. **First in, first out / first expiry, first out (FEFO)**: Your Warehouse Management System (WMS) should support the FEFO principle to ensure that products with the earliest expiry dates are dispatched first. 4. **Cycle counting**: Replace the traditional annual full stocktake with ongoing counts of a small proportion of inventory daily or weekly. This helps identify and correct discrepancies earlier, keeping system data accurate. 5. **Batch-level management**: All inventory operations must be managed at batch level to ensure that the movement of every product batch is recorded accurately.

📘 Regulatory basis

GDP requires inventory records to accurately reflect actual stock, including quantities and batch numbers. It also requires measures to prevent mix-ups and cross-contamination and compliance with the FEFO principle. These requirements place high demands on inventory management accuracy.

📗 Drew Tang's recommendations

We strongly recommend that clients invest in a fully functional barcode-scanning Warehouse Management System (WMS). Requiring product barcodes and location codes to be scanned at every stage, including receipt, put-away, picking, checking and dispatch, can greatly reduce human error and keep inventory data accurate in real time. This is standard equipment for modern pharmaceutical warehousing.

📕 Risk notice

Disorganised inventory management is a breeding ground for dispatching the wrong goods or expired medicines. Inaccurate stock data means your traceability system is unreliable, and you may be unable to locate products quickly in an urgent recall. If inspectors find significant discrepancies between inventory records and actual stock during an inspection, they may consider your entire warehousing operation to be out of control.

Q344 · 用于GDP活动中的计算机化系统(如WMS, ERP)需要满足哪些验证和管理要求?独立链接
Computerised systems used to manage critical GDP activities (such as warehouse management systems (WMS), enterprise resource planning systems (ERP) and temperature and humidity monitoring systems) must themselves be controlled to ensure that the data they generate are reliable, accurate and secure. These systems require Computer System Validation (CSV), with documented evidence demonstrating that they consistently meet their intended functions and regulatory requirements throughout their lifecycle. CSV generally follows the GAMP 5 (A Risk-Based Approach to Compliant GxP Computerized Systems) framework. Key management requirements include: 1. **Data integrity**: the system must be designed to ensure compliance with the ALCOA+ principles; 2. **Audit trail**: the system must automatically record all activities relating to the creation, modification and deletion of GxP data, including timestamps and operator information; 3. **Access controls**: grant users the minimum system access necessary for their roles and responsibilities; 4. **Backup and recovery**: validated procedures must be in place to back up data regularly and restore it reliably when required; 5. **Change control**: any changes to the system (such as software upgrades or configuration changes) must be managed through a formal change control procedure.

📘 Regulatory basis

GDP expressly requires that the suitability of a computerised system be demonstrated before it is used, usually through validation. The system must prevent unauthorised access or modification, provide an audit trail and allow data backup. Annex 11 of the EU GDP guidelines and US FDA 21 CFR Part 11 are generally accepted standards in this area.

📗 Drew Tang's recommendations

When procuring a new system, make “support for GxP compliance” a key selection criterion. Ask the supplier to provide relevant documentation on its software development and testing. For cloud services (SaaS), you need to audit the service provider's quality system and security measures. CSV is a specialist field; if you lack in-house experience, consider seeking external expert support to plan and carry out validation activities.

📕 Risk notice

Using an unproven, “black-box” computer system to manage your pharmaceutical stock and quality data is unacceptable to regulators. If your system lacks an audit trail, you will be unable to explain any changes to the data. An uncontrolled computer system is a major source of risk to data integrity and may be sufficient for the entire quality system to be judged non-compliant.

Q346 · 在设计或改造药品仓库时,有哪些关键的GDP布局要求需要考虑?独立链接
The core design principles for a GDP-compliant warehouse layout are to ensure clear goods flows, prevent mix-ups and cross-contamination, and provide suitable storage conditions. Key layout requirements include: 1. **Functional zoning**: clearly separate, physically or by other effective means, areas such as goods receipt, quarantine pending examination, storage of released goods, non-conforming goods, returns, recalled goods and dispatch. 2. **One-way flow**: design sensible goods-flow routes so that, as far as possible, medicines move in one direction from receipt to dispatch, avoiding unnecessary backtracking and crossovers. 3. **Adequate space**: ensure that all areas have enough space for orderly storage and operations, avoiding excessive stacking or blocked passageways. 4. **Environmental controls**: areas requiring special storage conditions, such as refrigeration, protection from light or ventilation, should be specifically designed and equipped with suitable facilities. 5. **Security**: offices, rest areas and other non-operational areas should be separated from medicine storage areas. Storage areas for controlled medicines require additional security measures.

📘 Regulatory basis

Chapter 3, “Premises and Equipment”, of the Good Distribution Practice (GDP) for Medicinal Products sets out clear requirements for the design and layout of storage areas, emphasising the importance of functional segregation, preventing mix-ups and cross-contamination, and providing appropriate storage conditions.

📗 Drew Tang's recommendations

When planning the warehouse layout, draw a detailed floor plan showing all functional areas and the flow of goods. This plan will be an important document for demonstrating your design approach to the regulatory authorities. When designing the receiving and dispatch areas, consider providing a sheltered area to protect medicines from adverse weather during loading and unloading. The warehouse floors, walls and ceilings should be made of materials that are easy to clean.

📕 Risk notice

A warehouse with a disorganised layout and unclear functional zones is a major problem area in a GDP inspection. If released goods, non-conforming goods and returned goods are stored together, inspectors will immediately conclude that your system presents a serious risk of medicine mix-ups and incorrect dispatch. This could directly result in a failed inspection or a requirement for you to suspend operations immediately and carry out remedial work.

Q349 · 一份详尽的内部审核(自我检查)报告应包含哪些内容?独立链接
An internal audit report is a key document for recording audit findings and driving subsequent improvements; its quality directly affects the effectiveness of the audit. A detailed report should be clearly structured and specific. It should include at least the following sections: 1. **Basic information**: unique audit reference, audit date, scope (such as “storage operations” or “document system”), audit criteria (such as GDP guidance or company SOPs), auditor’s name and the department audited. 2. **Audit summary**: a brief overview of the audit and its main conclusions. 3. **Audit findings**: the core of the report. Clearly list each non-conformity (deficiency) separately. Describe the specific facts observed in detail (“where I was and what I saw”) and cite the specific legislative or SOP provision breached. 4. **Deficiency grading**: grade each deficiency according to its potential impact on product quality and regulatory compliance (for example, “critical”, “major” or “minor”). 5. **Recommendations (optional)**: the auditor may suggest improvements, but the audited department should determine the final corrective actions. 6. **Report distribution list and conclusion**.

📘 Regulatory basis

Self-inspections must be recorded under the Good Distribution Practice (GDP) for Medicinal Products, and the records should include all observations and proposed corrective measures. A structured report is the standard way of meeting this requirement.

📗 Drew Tang's recommendations

When describing audit findings, remain objective and fact-based, and avoid subjective or accusatory language. A good finding should enable anyone reading it to recreate the situation. For example, instead of writing ‘staff training was inadequate’, write ‘In the third-floor warehouse, staff member Zhang San did not follow the picking steps in SOP-W-005. When asked, he said that he was not familiar with the SOP.’ Such a description is compelling and effectively points to the root cause.

📕 Risk notice

An internal audit report that is vague and lacking in detail is ineffective. It does not provide clear input for subsequent CAPA, nor does it demonstrate to the regulator that a thorough, professional self-inspection was carried out. If the report always says “everything is fine”, or the issues it raises are trivial, the regulator may suspect that your internal audits are merely a formality.

Q352 · 卫生署药物办公室进行例行视察时,通常会重点检查哪些方面?我们应该如何准备?独立链接
Routine inspections by the Department of Health are intended to ensure that licence holders continue to comply with the relevant legislation and codes of practice. Inspections are usually unannounced, although advance notice may also be given. The main areas checked include: 1. Premises and facilities: whether they meet the standards set at the time of licensing, particularly whether the warehouse environment for medicine storage meets the requirements. 2. Documents and records: the main focus of the inspection, including records of medicine purchases, sales and stock, as well as temperature monitoring and staff training records. 3. Operation of the Quality Management System: inspectors will sample-check whether your Standard Operating Procedures (SOPs) are being implemented effectively. 4. Personnel qualifications and responsibilities: ensuring that personnel in key roles have the relevant qualifications and clearly understand their responsibilities. To prepare, ensure all documents and records are well organised and readily accessible, and provide staff with regular training and mock inspection exercises so they can remain composed and answer questions accurately during an inspection.

📘 Regulatory basis

The Pharmacy and Poisons Ordinance (Cap. 138) authorises the Director of Health or an authorised person to enter licensed premises at any reasonable time to inspect whether the licence holder is complying with the requirements of the Ordinance.

📗 Drew Tang's recommendations

We view an inspection as a “free health check” of the company’s compliance system. Rather than responding passively, prepare proactively. We recommend that clients establish an “inspection preparation folder” containing copies or an index of all documents that may be reviewed. During the inspection, assign a senior employee familiar with the situation to accompany the inspectors throughout and answer questions clearly and accurately, making a positive impression of professionalism and rigour.

📕 Risk notice

Providing false or misleading information during an inspection is a serious offence. If incomplete records or signs of falsification are discovered, you may face severe penalties. In addition, obstructing inspectors in the performance of their duties may constitute a criminal offence. Cooperate with the inspection openly and honestly.

Q359 · 在药品库存管理方面,除了保证先进先出,还有哪些关键的合规要点?独立链接
Effective inventory management is central to ensuring medicine quality and safety. In addition to strictly applying the “first-expired-first-out” (FEFO) principle (that is, dispatching items with the earliest expiry date first, which is more accurate than FIFO), the following key compliance points apply: 1. Clear zoning: the warehouse must have clearly designated areas for quarantined goods pending examination, released goods, non-conforming goods, returned goods and recalled goods, with clear signs to distinguish them and prevent mix-ups and cross-contamination. 2. Environmental monitoring: medicines with specific temperature and humidity requirements must be monitored and recorded continuously, 24 hours a day, using calibrated equipment. There must be an emergency plan for environmental excursions, and actions taken must be documented. 3. Regular stocktakes: stock must be counted regularly, and physical inventory reconciled against stock records. Any discrepancies must be investigated and documented. 4. Expiry-date management: establish an expiry-date alert system and closely monitor medicines approaching their expiry date to prevent expired medicines from being dispatched accidentally. 5. Security: take appropriate security measures to prevent unauthorised access to storage areas and prevent medicines from being stolen or tampered with.

📘 Regulatory basis

The Code of Practice for Licensed Wholesale Dealers sets out detailed requirements for the storage, stock control and distribution of medicines, requiring licensees to take all necessary measures to maintain medicine quality throughout the supply chain.

📗 Drew Tang's recommendations

We recommend that clients treat stock management as a dynamic process. An electronic inventory system using barcodes or RFID can greatly improve the accuracy of FEFO implementation, stocktaking efficiency and medicines tracking. For high-value or controlled medicines, consider higher-level security measures, such as a separate locked storage area and video surveillance. Regular inventory analysis can also help optimise procurement planning and reduce tied-up capital and losses from expired products.

📕 Risk notice

Disorganised inventory management creates conditions in which medicine quality problems can arise. Accidentally supplying non-conforming or expired goods to customers can lead not only to complaints and commercial losses, but also to medicine safety incidents, regulatory penalties and legal liability. Medicines deteriorating because of improper storage conditions is likewise a serious breach.

Q371 · 我们的药品仓库应该如何进行有效的虫害控制?独立链接
Effective pest control is essential for preventing contamination of medicines and maintaining hygienic storage conditions. You need to establish a comprehensive pest management programme. This involves more than simply placing a few mousetraps. The programme should include: 1. Prevention measures, which are the most important part. These include maintaining the building structure in good condition, sealing all potential pest entry routes (such as holes in walls and gaps around doors and windows), keeping the premises and surrounding area clean, and eliminating food sources and standing water. 2. Inspection and monitoring: inspections should be carried out regularly by trained personnel or a professional pest control company, and monitoring devices (such as glue boards and mousetraps) should be placed at key locations (such as entrances and corners), with their locations shown on a plan. 3. Treatment and reporting: if pest activity is detected, appropriate measures that will not contaminate medicines must be taken immediately and documented. Detailed records of all inspection, monitoring and treatment activities must include the date, findings, actions taken and the person responsible.

📘 Regulatory basis

Both the Code of Practice for Licensed Wholesale Dealers and GMP guidance set out clear requirements for the hygiene conditions of premises, emphasising that measures must be taken to prevent insects, rodents and other animals from entering and contaminating medicines.

📗 Drew Tang's recommendations

We recommend that clients enter into an annual service contract with a reputable specialist pest control company experienced in handling pharmaceutical or food warehouses. As well as providing professional services, it can provide complete reports and trend analyses that meet regulatory requirements. When selecting insecticides or rodenticides, ensure that they are approved for use and will not pose a contamination risk to medicines.

📕 Risk notice

Signs of pests (such as droppings or gnaw marks) are among the “critical defects” that Department of Health inspectors pay close attention to. If pest activity is found in a drug storage area, all drugs in that area may be deemed contaminated and need to be quarantined and destroyed. This is not only a financial loss but also a serious blow to your Quality Management System.

Q372 · 什么是仓库的“温度图谱研究”(Temperature Mapping Study)?我们必须做吗?独立链接
A temperature mapping study (also known as temperature distribution validation) is a scientific validation exercise. It involves placing sufficient temperature probes at different locations within a warehouse or cold room, including high, low and middle positions and locations near doors, windows and air-conditioning outlets, and continuously recording data over a period of time (usually 7 consecutive days, covering the hottest and coldest seasons). The aim is to identify the hottest and coldest points in the warehouse and demonstrate that temperatures throughout the storage space can be maintained consistently within the specified range, such as 15–25°C or 2–8°C. For all pharmaceutical wholesalers and manufacturers requiring temperature-controlled storage, temperature mapping studies are a mandatory GDP/GMP requirement. They form the basis for demonstrating that your storage facilities can continuously safeguard medicine quality.

📘 Regulatory basis

Both the Code of Practice for Licensed Wholesale Dealers and the PIC/S GDP/GMP guidelines expressly require temperature mapping studies to be conducted before a new temperature-controlled storage area is brought into use, to confirm its performance. Revalidation is required after major refurbishment.

📗 Drew Tang's recommendations

We recommend outsourcing temperature mapping studies to a specialist validation service provider. On completion of the study, you will receive a detailed report. This report should guide you to place routine monitoring probes at the “worst-case” locations identified by the study (the hottest and coldest points), because if these locations meet requirements, the temperatures in other areas are likely to meet them too. The study should be repeated periodically (for example, every 3 years) or whenever there is a major change to the warehouse layout.

📕 Risk notice

Without a temperature mapping study, or if the study is not properly conducted, you cannot scientifically demonstrate that your warehouse meets temperature-control requirements. This will be regarded as a major deficiency during a Department of Health inspection. If your routine temperature-monitoring probe happens to be placed in the “good” location where the temperature is most stable, while the hottest spot has already exceeded limits, all your temperature records may be invalid and the quality of the medicines stored may be at serious risk.

Q384 · 如果我们的仓库温控空调系统在夜间发生故障,导致温度超出范围,我们该怎么办?独立链接
This is an emergency that must be handled immediately and systematically. First, once the fault is detected through the alarm system, send someone to the site immediately to assess the situation and arrange repairs as soon as possible. Second, record the incident immediately as a “deviation”, noting when the fault occurred, when the temperature first went out of range, the highest temperature reading, and the affected areas and medicines. Third, immediately quarantine all affected medicines in the “quarantined goods pending examination” area and label them clearly. They must not be dispatched under any circumstances. Fourth, contact the manufacturer of the medicines concerned or consult their stability data to assess the specific impact of this brief temperature excursion on medicine quality. Some medicines may tolerate short-term temperature fluctuations for a certain period, while others are highly sensitive. Finally, the medicines may be considered for release again only after a written assessment from the manufacturer confirms that their quality has not been affected. Otherwise, they must be destroyed in accordance with the procedure. The entire process must be fully documented.

📘 Regulatory basis

The Code of Practice for Licensed Wholesale Dealers requires storage conditions to be monitored continuously, with any deviations investigated and recorded. This is a core requirement of the quality management system.

📗 Drew Tang's recommendations

Prevention is better than cure. We strongly recommend that clients install backup air-conditioning systems and generators in critical temperature-controlled warehouses. A reliable 24-hour temperature alarm system with remote notifications is an essential investment. Establish communication channels with medicine manufacturers in advance so that technical support can be obtained quickly if such an incident occurs. Prepare a detailed emergency SOP and conduct drills with staff to ensure they know what to do in a real emergency.

📕 Risk notice

Mishandling a temperature excursion or attempting to conceal it is extremely dangerous. Supplying medicines that may have deteriorated to customers directly endangers patient safety. If a Department of Health inspection finds that you have temperature excursion records but did not investigate or deal with them appropriately, this will be considered a critical deficiency, demonstrating a complete failure of your quality system and potentially justifying suspension or revocation of your licence.

Q387 · 对于退回、拒收或召回的药品,具体的记录和管理要求是什么?独立链接
Managing returned, rejected and recalled medicines is a key control point for preventing non-conforming goods from re-entering the market. You must establish strict procedures and a record system. First, all such medicines must be immediately segregated in a dedicated, secure, clearly identified physical area and must not be mixed with released goods. Second, every return, rejection or recall must be documented in detail, including the medicine name, batch number, quantity, source (customer), reason and date received. Third, the quality department must assess the medicines and decide on their final disposition. There are only three possible outcomes: a) if it can be confirmed that the medicine’s quality has not been affected (for example, it was simply sent in error and transport conditions were controlled throughout), it may be returned to stock with approval from the head of the quality department; b) if it needs to be destroyed, follow the destruction procedure; or c) if it has been recalled, handle it in accordance with the recall plan. All assessments, decisions and final disposition actions must be documented.

📘 Regulatory basis

The Code of Practice for Licensed Wholesale Dealers has dedicated chapters on handling returned goods and recalls, requiring written procedures and complete records to be maintained.

📗 Drew Tang's recommendations

We recommend that clients design dedicated record forms for these “problem medicines” to ensure that all required information is captured. Provide dedicated training to warehouse staff responsible for handling returns so that they understand the importance of segregation and record-keeping. Conduct regular stocktakes in the quarantine area to ensure that physical stock matches the records. Take particular care when deciding whether high-value returned goods can be returned to stock; if in any doubt, destroy them.

📕 Risk notice

Failure to effectively segregate and control non-conforming goods is a “critical deficiency” in a GDP inspection. If inspectors find recalled goods that should have been segregated stored together with released goods, or you cannot provide the final disposition record for a batch of returned goods, this indicates a serious risk that unsafe medicines could re-enter the market and may lead to immediate regulatory action.

Q388 · 我们应该如何校准我们的关键测量设备,例如仓库的温度探头和实验室的电子天平?独立链接
Equipment calibration is fundamental to ensuring that measurement data is accurate and reliable, and is a prerequisite for data integrity. You must establish a calibration programme for all critical equipment that affects the quality of medicines. The programme should include: 1. Equipment list: list all equipment requiring calibration. 2. Calibration frequency: set a reasonable calibration interval according to the importance and stability of the equipment (for example, calibrate temperature probes annually and electronic balances quarterly). 3. Calibration method: specify the standards and procedures used for calibration. Calibration must be traceable; the standards used for calibration must themselves be traceable to higher-level national or international standards. 4. Implementation and records: calibration may be carried out by competent internal personnel or outsourced to a qualified external organisation (such as a HOKLAS-accredited laboratory). Each calibration must be documented in detail in a calibration certificate, including readings before and after calibration, whether the equipment passed, and the name of the person performing it and the date. All calibrated equipment should be labelled with the date of the latest calibration and the date of the next calibration.

📘 Regulatory basis

Both GMP and GDP guidelines expressly require key equipment used for measurement, weighing, recording and control to be calibrated and checked regularly, with relevant records retained.

📗 Drew Tang's recommendations

We recommend that clients centrally manage calibration plans and records for all critical equipment, using a simple spreadsheet or specialist equipment management software to track due dates and prevent anything being overlooked. If calibration shows that equipment is outside tolerance, a deviation investigation must be initiated to assess the validity of all measurement data affected by the equipment since its last satisfactory calibration, and determine whether product quality was affected.

📕 Risk notice

Data generated using equipment that has not been calibrated or is overdue for calibration is invalid. For example, if the temperature records in your warehouse were generated by a probe that reads 2°C below the true temperature, all your “compliant” temperature records are false, and the medicines may already have been exposed to temperatures outside the permitted range. During an inspection, checking the calibration labels and certificates of critical equipment is a standard requirement; any omission will be recorded as a deficiency.

Q391 · 我们的年度自检(Self-Inspection)应该由谁来执行才能保证其客观性?独立链接
The purpose of annual self-inspection is to conduct a critical and honest assessment of your own Quality Management System, so objectivity and independence are essential. To ensure this, the people or team conducting the self-inspection should be as independent as possible from the activities being inspected. Best practice is to: 1. Form a self-inspection team with members from different departments—for example, have production staff inspect the warehouse and warehouse staff inspect the quality control laboratory, creating cross-checks. 2. Appoint a member of management who is not directly responsible for specific operations, such as the quality assurance manager, to lead the team. 3. If the company’s size and resources permit, engage an independent external consultant or auditor to conduct the self-inspection. This can provide the most objective perspective and may bring experience of industry best practices. Regardless of who conducts it, self-inspection personnel must receive appropriate training and be familiar with GDP/GMP requirements and auditing techniques.

📘 Regulatory basis

Both the Code of Practice for Licensed Wholesale Dealers and GMP guidance require self-inspections to be conducted by designated, competent personnel who are independent of the department being inspected, to ensure that the inspection is impartial and thorough.

📗 Drew Tang's recommendations

We do not recommend that department heads inspect their own departments, as genuine objectivity is difficult to achieve. Treat self-inspection as an opportunity for internal learning and improvement, not fault-finding. Be open to issues identified by external auditors. Rengangyongsheng (Hong Kong) Limited provides professional third-party self-inspection services to help you review your systems from a fresh perspective and prepare for an official inspection.

📕 Risk notice

A superficial “friendly” self-inspection carried out by non-independent personnel will almost certainly miss many potential problems. This can give management the false impression that “everything is fine” and cause them to lower their guard. When Department of Health inspectors arrive and find numerous problems, you will have to address not only the problems themselves but also explain why your self-inspection system failed to identify them, making the situation worse.

Q420 · 我们仓库里有一批过期的药品,应该如何处理?可以直接当垃圾丢弃吗?独立链接
Absolutely not. Expired medicines must not be discarded as ordinary rubbish. They are subject to strict disposal requirements to prevent them from re-entering the market or polluting the environment. As a licensed wholesaler or manufacturer, you must establish a formal medicine destruction procedure. First, isolate the expired medicines and label them clearly. Then engage a qualified chemical waste collector to handle them. Detailed records of the entire destruction process must be kept, including the medicine name, batch number, quantity, destruction date and method. At least two staff members, one of whom should be a manager, must jointly supervise and sign to confirm the process. These records must be available for inspection, and the Department of Health may request them during an inspection.

📘 Regulatory basis

Both the Good Distribution Practice (GDP) for Wholesale Dealers in Medicines and the Waste Disposal (Chemical Waste) (General) Regulation set out clear requirements for handling expired medicines and retaining records.

📗 Drew Tang's recommendations

We recommend that clients include the medicines destruction procedure in the company’s Standard Operating Procedures (SOPs) and review it regularly. It is essential to choose a reputable chemical waste disposal company holding the appropriate licence. Keep all destruction contracts and records for inspection.

📕 Risk notice

Improper handling of expired medicines, such as casually discarding or reselling them, is a serious violation. If discovered, this not only breaches medicines management regulations but may also contravene environmental legislation, resulting in penalties under both. If the medicines ultimately endanger public health, the consequences could be severe.

Q437 · 我是否可以将药品存放在持牌地址以外的地方,例如迷你仓?独立链接
Absolutely not. Under Hong Kong law, all regulated medicines, whether Western medicines or proprietary Chinese medicines, must be stored at licensed premises specified on the licence and approved by the regulatory authority. The facilities at these premises, including temperature and humidity controls, security systems and fire prevention measures, are subject to rigorous scrutiny to ensure the quality and safety of the medicines. Unapproved external storage locations, such as offices, homes or mini-storage units, do not meet statutory storage requirements. Storing medicines at these locations is a serious breach.

📘 Regulatory basis

Both the Good Distribution Practice (GDP) for Wholesale Dealers in Medicines and guidance such as the GMP for proprietary Chinese medicines strictly require medicines to be stored at qualified premises.

📗 Drew Tang's recommendations

If your licensed warehouse does not have sufficient capacity, the only lawful solution is to apply to expand the area of the existing licensed premises or apply for a new, suitably qualified licensed warehouse. Rengangyongsheng (Hong Kong) Limited can assist you in finding suitable storage space and completing the licence application or change procedure.

📕 Risk notice

Storing medicines at an unapproved location not only puts their quality at risk; more seriously, if this is discovered, the regulatory authorities may consider that you are attempting to conceal or distribute medicines of unknown origin, triggering a serious loss of trust and disciplinary action.

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗